ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nucleotide sugars
Tom Snelling(The University of Sydney), Philip Cohen(MRC Protein Phosphorylation and Ubiquitylation Unit)
Cited by 21
Related Papers
GSK3 takes centre stage more than 20 years after its discovery
|Biochemical Journal|2001|1.3k
Kinase drug discovery 20 years after imatinib: progress and future directions
|Nature Reviews Drug Discovery|2021|1k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
|Journal of Biological Chemistry|1999|717
Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ϵ
|Journal of Biological Chemistry|2009|382